扩展神经元蜡样脂褐质沉积症的神经影像表型
该研究回顾性分析24例经基因证实的神经元蜡样脂褐质沉积症患者的40次脑MR检查,描述丘脑T2/FLAIR低信号、脑室周围及深部白质、内囊后肢、腹侧脑桥、岛叶/岛叶下区高信号及幕上幕下萎缩等征象,并报告从发病到诊断的中位时间差为1.5年。
要点
- 丘脑T2/FLAIR低信号(22例)与脑室周围及深部白质高信号(22例)是最常见的初始MR征象。
- 内囊后肢(22例)和腹侧脑桥(19例)高信号比既往文献报告更常见,岛叶/岛叶下区高信号为首次报告。
- CLN2、CLN5和CLN7病表现为小脑萎缩较大脑萎缩更显著。
关键影像表现/征象
- 初始脑MR显示丘脑T2/FLAIR低信号(22例)。
- 脑室周围及深部白质T2/FLAIR高信号(22例)。
- 内囊后肢T2/FLAIR高信号(22例)。
- 腹侧脑桥T2/FLAIR高信号(19例)和岛叶/岛叶下区高信号(18例)。
- 幕上萎缩(21例)和幕下萎缩(20例);9例有随访影像的患者中8例显示进展性改变。
诊断标准与关键数值
- 丘脑T2/FLAIR低信号见于22例。
- 脑室周围及深部白质T2/FLAIR高信号见于22例。
- 内囊后肢T2/FLAIR高信号见于22例。
- 腹侧脑桥T2/FLAIR高信号见于19例。
- 岛叶/岛叶下区T2/FLAIR高信号见于18例。
临床应用与阅片要点
- 在疑似神经元蜡样脂褐质沉积症的患儿中,应关注丘脑T2/FLAIR低信号及深部白质、内囊后肢、腹侧脑桥高信号。
- 岛叶/岛叶下区异常信号可作为新的影像学线索。
- 注意小脑萎缩较大脑萎缩更显著提示CLN2、CLN5或CLN7病。
- 从发病到诊断的中位时间差为1.5年,提示影像识别可能有助于缩短诊断延迟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Neuronal ceroid lipofuscinoses are a group of neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigments in neuronal cells. As a result of storage material in the brain and retina, clinical manifestations include speech delay, cognitive dysfunction, motor regression, epilepsy, vision loss, and early death. At present, 14 different ceroid lipofuscinosis (CLN) genes are known. Recently, the FDA approved the use of recombinant human proenzyme of tripeptidyl-peptidase 1 for CLN2 disease, while phase I/IIa clinical trials for gene therapy in CLN3 and CLN6 are ongoing. Early diagnosis is, therefore, key to initiating treatment and arresting disease progression. Neuroimaging features of CLN1, CLN2, CLN3, and CLN5 diseases are well-described, with sparse literature on other subtypes. We aimed to investigate and expand the MR imaging features of genetically proved neuronal ceroid lipofuscinoses subtypes at our institution and also to report the time interval between the age of disease onset and the diagnosis of neuronal ceroid lipofuscinoses.
MATERIALS AND METHODS: We investigated and analyzed the age of disease onset and neuroimaging findings (signal intensity in periventricular, deep, and subcortical white matter, thalami, basal ganglia, posterior limb of the internal capsule, insular/subinsular regions, and ventral pons; and the presence or absence of supratentorial and/or infratentorial atrophy) of patients with genetically proved neuronal ceroid lipofuscinoses at our institution. This group consisted of 24 patients who underwent 40 brain MR imaging investigations between 1993 and 2019, with a male preponderance (male/female ratio = 15:9).
RESULTS: The mean ages of disease onset, first brain MR imaging, and diagnosis of neuronal ceroid lipofuscinoses were 4.70 ± 3.48 years, 6.76 ± 4.49 years, and 7.27 ± 4.78 years, respectively. Findings on initial brain MR imaging included T2/FLAIR hypointensity in the thalami (n = 22); T2/FLAIR hyperintensity in the periventricular and deep white matter (n = 22), posterior limb of the internal capsule (n = 22), ventral pons (n = 19), and insular/subinsular region (n = 18); supratentorial (n = 21) and infratentorial atrophy (n = 20). Eight of 9 patients who had follow-up neuroimaging showed progressive changes.
CONCLUSIONS: We identified reported classic neuroimaging features in all except 1 patient with neuronal ceroid lipofuscinoses in our study. CLN2, CLN5, and CLN7 diseases showed predominant cerebellar-over-cerebral atrophy. We demonstrate that abnormal signal intensity in the deep white matter, posterior limb of the internal capsule, and ventral pons is more common than previously reported in the literature. We report abnormal signal intensity in the insular/subinsular region for the first time. The difference in the median time from disease onset and diagnosis was 1.5 years.
引用
- Biswas A, Krishnan P, Amirabadi A, et al. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses. AJNR Am J Neuroradiol. 2020. PMID: 32855186. doi:10.3174/ajnr.A6726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。